EPO is a hormone your kidneys naturally produce to signal your bone marrow to make more red blood cells. The drug version, called recombinant human erythropoietin, is a lab-made copy of that hormone used to treat severe anemia. It’s also one of the most infamous performance-enhancing drugs in endurance sports, particularly cycling.
How EPO Works in Your Body
Your kidneys constantly monitor oxygen levels in your blood. When oxygen drops, whether from blood loss, altitude, or disease, your kidneys release erythropoietin into the bloodstream. EPO travels to the bone marrow and locks onto receptors on immature red blood cell precursors. This triggers those precursor cells to multiply and mature into fully functional red blood cells, while also protecting them from dying off prematurely. The result is more red blood cells circulating through your body, carrying more oxygen to your muscles and organs.
In healthy adults, normal EPO levels in the blood range from about 3 to 20 mU/mL. People with kidney disease often can’t produce enough EPO on their own, which is why anemia is so common in that population. The synthetic drug version works by mimicking exactly what the natural hormone does: binding to the same receptors and kickstarting the same red blood cell production process.
Medical Uses
The two primary reasons doctors prescribe EPO drugs are anemia from chronic kidney disease and anemia caused by chemotherapy in cancer patients. In both cases, treatment is typically reserved for patients whose hemoglobin has dropped below 10 g/dL, a level where fatigue, weakness, and shortness of breath become significant problems. For kidney disease patients, damaged kidneys simply can’t make enough of the hormone. For cancer patients, chemotherapy suppresses the bone marrow’s ability to produce blood cells.
EPO is given as an injection, either into a vein or under the skin. Kidney disease patients on hemodialysis typically receive it intravenously three times a week. Cancer patients on chemotherapy may receive it once weekly. The goal isn’t to push red blood cell counts as high as possible. It’s to raise them just enough to reduce symptoms and avoid blood transfusions, because pushing levels too high carries serious cardiovascular risks.
Different Versions of the Drug
The original synthetic EPO (epoetin alfa, sold as Epogen and Procrit) closely mirrors the natural hormone. It works well but clears the body relatively quickly, which is why most patients need injections two to three times per week.
A newer version called darbepoetin alfa (sold as Aranesp) was engineered with extra sugar molecules attached to its surface, which slows how fast the body breaks it down. According to data from the European Medicines Agency, darbepoetin has roughly three times the half-life of standard EPO when given intravenously. That means patients can maintain the same hemoglobin levels with injections just once a week or even once every two weeks, with no loss in effectiveness. A third-generation version, a pegylated form, extends the dosing interval even further for some kidney disease patients.
Why Athletes Use It
More red blood cells means more oxygen delivered to working muscles, which is exactly what endurance athletes want. EPO became the drug of choice in professional cycling, distance running, and cross-country skiing starting in the late 1980s and 1990s. It was central to the doping scandals that brought down Lance Armstrong and implicated entire teams in the Tour de France.
A systematic review in BMJ Open Sport and Exercise Medicine found low-to-moderate quality evidence that synthetic EPO improves VO2 max (the body’s maximum oxygen uptake) compared to placebo across all dosage levels. The improvements were statistically significant regardless of whether athletes used low, medium, or high doses. EPO also increased maximal power output and time to exhaustion. However, the review noted something important: these gains showed up almost exclusively at maximum exercise intensities, which may be less directly relevant to the pacing strategies athletes use in actual competition.
Health Risks
The core danger of EPO, whether used medically or for doping, is what happens when you have too many red blood cells. Blood becomes thicker and more viscous, forcing the heart to work harder to pump it through your vessels. The FDA has issued safety communications warning that EPO drugs can increase the risk of heart attack, heart failure, stroke, and blood clots. These risks apply to patients using the drug for approved medical conditions, not just athletes abusing it at high doses.
For athletes using EPO without medical supervision, the risks are amplified. They’re typically pushing their red blood cell counts well above normal levels, and they’re doing so without the blood monitoring that hospital patients receive. Dehydration during intense exercise thickens the blood even further. A cluster of unexplained deaths among young European cyclists in the late 1980s and early 1990s was widely attributed to EPO abuse, though direct causation was never definitively proven in most cases.
How Anti-Doping Agencies Detect It
Detecting EPO abuse is tricky because the synthetic version does the same thing as the natural hormone. Anti-doping labs use a method based on a key difference: the lab-made and natural versions of EPO have slightly different molecular structures, particularly in their size and electrical charge.
The standard detection technique, originally developed by French researcher Françoise Lasne, works in four steps: concentrating a urine sample, separating proteins by their electrical charge, transferring them to a membrane, and then using a chemical reaction that produces light to reveal the EPO pattern. Natural EPO and synthetic EPO show up in different positions on the test because of their structural differences. Labs can also use a technique that separates proteins by size, since recombinant and natural EPO have different apparent molecular weights.
Beyond direct urine testing, the World Anti-Doping Agency uses the Athlete Biological Passport, which tracks an athlete’s blood values over time. Sudden jumps in red blood cell counts or hemoglobin that can’t be explained by altitude training or illness raise red flags, even if no banned substance is found in a single test. This longitudinal approach has made EPO doping significantly harder to hide than it was in the 1990s, when there was no reliable test at all.